Dr.DHM
ActiveSummary
Dr.DHM has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €267k and a net result of €261k. Equity is growing by ~29.9% per year across the filed fiscal years. Its solvency ranks better than 44% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency81▲+9
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20k at 30 days acceptable
Liquidity ample (current ratio 1.79 against 1.52 in 2024; short-term debt: 43.8% and cash: 10.8% of total assets), and 43.9% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.1%
Return on assets
54.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
30 d late
2024
54 d late
2023
145 d late
2022
60 d late
2021
31 d late
2020
52 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€267k▲ 8.1%
2024 · €247k
2020: €-3klowest in 6 years
2021: €33k▲ +1373% vs 2020
2022: €144k▲ +331% vs 2021
2023: €322k▲ +123% vs 2022highest in 6 years
2024: €247k▼ -23.3% vs 2023
2025: €267k▲ +8.1% vs 2024
2020 → 2025
Total assets
€476k▼ 8.6%
2024 · €521k
2020: €4klowest in 6 years
2021: €57k▲ +1242% vs 2020
2022: €146k▲ +158% vs 2021
2023: €358k▲ +145% vs 2022
2024: €521k▲ +45.3% vs 2023highest in 6 years
2025: €476k▼ -8.6% vs 2024
2020 → 2025
Net result
€261k▲ 16.1%
2024 · €225k
2020: €-9klowest in 6 years
2021: €36k▲ +519% vs 2020
2022: €111k▲ +207% vs 2021
2023: €202k▲ +82.1% vs 2022
2024: €225k▲ +11.6% vs 2023
2025: €261k▲ +16.1% vs 2024highest in 6 years
2020 → 2025
Working capital
€165k▲ 14.9%
2024 · €143k
2020: €-3klowest in 6 years
2021: €31k▲ +1285% vs 2020
2022: €142k▲ +357% vs 2021
2023: €317k▲ +123% vs 2022highest in 6 years
2024: €143k▼ -54.7% vs 2023
2025: €165k▲ +14.9% vs 2024
2020 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€33k-€144k▲ 331%€322k▲ 123%€247k▼ 23.3%€267k▲ 8.1%
2021: €33klowest in 5 years
2022: €144k▲ +331% vs 2021
2023: €322k▲ +123% vs 2022highest in 5 years
2024: €247k▼ -23.3% vs 2023
2025: €267k▲ +8.1% vs 2024
Operating result€46k-€144k▲ 216%€266k▲ 83.8%€296k▲ 11.5%€343k▲ 15.9%
2021: €46klowest in 5 years
2022: €144k▲ +216% vs 2021
2023: €266k▲ +83.8% vs 2022
2024: €296k▲ +11.5% vs 2023
2025: €343k▲ +15.9% vs 2024highest in 5 years
Net result€36k-€111k▲ 207%€202k▲ 82.1%€225k▲ 11.6%€261k▲ 16.1%
2021: €36klowest in 5 years
2022: €111k▲ +207% vs 2021
2023: €202k▲ +82.1% vs 2022
2024: €225k▲ +11.6% vs 2023
2025: €261k▲ +16.1% vs 2024highest in 5 years
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 16% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €476k
Fixed assets
€103k ▼ 1.2%
Current assets
€373k ▼ 10.4%
Equity and liabilities €476k
Equity
€267k ▲ 8.1%
Debt
€209k ▼ 23.7%
Debt's share of the balance-sheet total falls from 52.5% to 43.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€345k▲
2024 · €298k
Cash flow
€263k▲
2024 · €227k
Current ratio
1.79▲
2024 · 1.52
Debt to equity
0.78▼
2024 · 1.11
ROE
97.7%▲
2024 · 91.0%
ROA
54.8%▲
2024 · 43.2%
Interest coverage
1889.46▲
2024 · 1526.86
Debt ≤ 1 year
€209k▼
2024 · €273k
Income taxes
€82k▲
2024 · €71k
Staff costs
€19k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet
Code20242025
Assets
Total assets20/58€521k€476k▼
Fixed assets21/28€104k€103k▼
Tangible fixed assets22/27€4k€3k▼
Plant, machinery and equipment23€3k€3k▼
Furniture and vehicles24€777-
Financial fixed assets28€100k€100k=
Current assets29/58€417k€373k▼
Amounts receivable within one year40/41€50k€161k▲
Trade receivables40-€890
Other amounts receivable41€50k€160k▲
Cash at bank and in hand54/58€193k€52k▼
Deferred charges and accrued income490/1€174k€161k▼
Equity and liabilities
Total equity and liabilities10/49€521k€476k▼
Equity10/15€247k€267k▲
Contributions10/11€6k€6k=
Profit (loss) carried forward14€241k€261k▲
Amounts payable17/49€274k€209k▼
Amounts payable within one year42/48€273k€209k▼
Trade debts44€7k€7k▲
Suppliers440/4€7k€7k▲
Advances received on contracts in progress46-€2k
Taxes, remuneration and social security45€23k€10k▼
Taxes450/3€23k€8k▼
Remuneration and social security454/9-€2k
Other amounts payable47/48€243k€189k▼
Accrued charges and deferred income492/3€168€168=
Income statement
Code20242025
Remuneration, social security and pensions62-€19k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€2k▲
Other operating charges640/8€608€668▲
Gross operating margin9900€298k€365k▲
Operating profit (loss)9901€296k€343k▲
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€195€183▼
Recurring financial charges65€195€183▼
Profit (loss) for the period before taxes9903€296k€343k▲
Income taxes67/77€71k€82k▲
Profit (loss) for the period9904€225k€261k▲
Profit (loss) for the period to be appropriated9905€225k€261k▲
Appropriation of the result
Profit (loss) to be appropriated9906€541k€502k▼
Profit (loss) brought forward from the previous period14P€316k€241k▼
Profit to be distributed694/7€300k€241k▼
Return on contributions (dividend)694€300k€241k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | - | €19k | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €362 | €570 | €2k | €2k | €2k | ▲ 13.1% |
| Other operating charges640/8 | €688 | €62 | €771 | €608 | €668 | ▲ 9.8% |
| Gross operating margin9900 | €47k | €145k | €268k | €298k | €365k | ▲ 22.4% |
| Operating profit (loss)9901 | €46k | €144k | €266k | €296k | €343k | ▲ 15.9% |
| Financial income75/76B | - | €13 | - | €0 | - | - |
| Recurring financial income75 | - | €13 | - | €0 | - | - |
| Financial charges65/66B | €345 | €260 | €196 | €195 | €183 | ▼ 6.3% |
| Recurring financial charges65 | €345 | €260 | €196 | €195 | €183 | ▼ 6.3% |
| Profit (loss) for the period before taxes9903 | €45k | €144k | €265k | €296k | €343k | ▲ 15.9% |
| Income taxes67/77 | €9k | €34k | €64k | €71k | €82k | ▲ 15.4% |
| Profit (loss) for the period9904 | €36k | €111k | €202k | €225k | €261k | ▲ 16.1% |
| Profit (loss) for the period to be appropriated9905 | €36k | €111k | €202k | €225k | €261k | ▲ 16.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €57k | €146k | €358k | €521k | €476k | ▼ 8.6% |
| Fixed assets21/28 | €2k | €2k | €5k | €104k | €103k | ▼ 1.2% |
| Tangible fixed assets22/27 | €2k | €2k | €5k | €4k | €3k | ▼ 32.6% |
| Plant, machinery and equipment23 | - | - | €4k | €3k | €3k | ▼ 15.5% |
| Furniture and vehicles24 | €2k | €2k | €1k | €777 | - | - |
| Financial fixed assets28 | - | - | - | €100k | €100k | = |
| Current assets29/58 | €54k | €144k | €353k | €417k | €373k | ▼ 10.4% |
| Amounts receivable within one year40/41 | €4k | €22k | €46k | €50k | €161k | ▲ 222% |
| Trade receivables40 | €4k | €4k | €20k | - | €890 | - |
| Other amounts receivable41 | - | €18k | €26k | €50k | €160k | ▲ 220% |
| Cash at bank and in hand54/58 | €5k | €42k | €192k | €193k | €52k | ▼ 73.3% |
| Deferred charges and accrued income490/1 | €45k | €80k | €115k | €174k | €161k | ▼ 7.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €57k | €146k | €358k | €521k | €476k | ▼ 8.6% |
| Equity10/15 | €33k | €144k | €322k | €247k | €267k | ▲ 8.1% |
| Contributions10/11 | €6k | €6k | €6k | €6k | €6k | = |
| Capital10 | €6k | - | - | - | - | - |
| Issued capital100 | €6k | - | - | - | - | - |
| Profit (loss) carried forward14 | €27k | €138k | €316k | €241k | €261k | ▲ 8.3% |
| Amounts payable17/49 | €23k | €2k | €36k | €274k | €209k | ▼ 23.7% |
| Amounts payable within one year42/48 | €23k | €2k | €36k | €273k | €209k | ▼ 23.7% |
| Trade debts44 | €2k | €1k | €21k | €7k | €7k | ▲ 4.1% |
| Suppliers440/4 | €2k | €1k | €21k | €7k | €7k | ▲ 4.1% |
| Advances received on contracts in progress46 | - | - | - | - | €2k | - |
| Taxes, remuneration and social security45 | €10k | €877 | €15k | €23k | €10k | ▼ 57.4% |
| Taxes450/3 | €10k | €877 | €15k | €23k | €8k | ▼ 67.5% |
| Remuneration and social security454/9 | - | - | - | - | €2k | - |
| Other amounts payable47/48 | €11k | - | - | €243k | €189k | ▼ 22.2% |
| Accrued charges and deferred income492/3 | €168 | €168 | €168 | €168 | €168 | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €36k | €111k | €202k | €225k | €261k | ▲ 16.1% |
| + Depreciation and write-downs630 | €362 | €570 | €2k | €2k | €2k | ▲ 13.1% |
| Operating cash flow (approximation) | €36k | €111k | €203k | €227k | €263k | ▲ 16.1% |
| Investment in fixed assets (approximation) | - | €0 | €-5k | €-100k | €-545 | ▲ 99.5% |
| Change in cash | - | €37k | €149k | €1k | €-142k | ▼ 9,874% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 30 days late
2025
31-12
Financial
Highest result since 2020net €261k ▲16.1%
Operating result €343k, net result €261k, both a record.
23-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 54 days late
2024
23-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 145 days late
2023
31-12
Financial
Equity above €200kEq €322k ▲123%
3 profitable years in a row build equity to €322k.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-12
Financial
Liquidity times 30current ratio 71.12
Current ratio from 2.35 to 71.12; short-term debt falls from €23k to €2k.
31-12
Financial
Equity above €100kEq €144k ▲331%
2 profitable years in a row build equity to €144k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Back to profitnet €36k
Net result €36k after one loss-making year.
31-12
Financial
Liquidity quadruplescurrent ratio 2.35
Current ratio from 0.62 to 2.35.
21-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 52 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rotselaar · 2 establishment units since 2020
Ground area
1,793 m²
Building footprint
693 m²
Volume, LiDAR
3,376 m³
2 parcels, Flanders · tallest building 9.9 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
2 establishment units
Dr.DHM
since 20202.308.320.084
Geetsvondelstraat 5, 3120 Tremelo
since 20252.381.672.375
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24123A0829/00A000 | Flanders | 1,467 m² | 1 · 176 m² | 9.8 m · 2 fl. |
| 24109C0621/00C000 | Flanders | 326 m² | 1 · 517 m² | 8.9 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.
Similar companies · same sector, comparable size
DOCTEUR SOPHIE ANRIJS PNEUMOLOGIE SPRL
BE 0847.977.859
Chaumont-Gistoux · Eq €267,209
Dr. Ine De Ruyck
BE 0782.566.306
Tielt · Eq €267,401
Dr. Mieke Tack
BE 0667.861.331
Rotselaar · Eq €267,080
CABINET D'ORTHOPEDIE STAINIER
BE 0464.304.158
Lobbes · Eq €267,067
DR. LISSENS MARK
BE 0463.851.723
Geel · Eq €267,429
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 6,683 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-10-2020
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
86220Specialist medical practice
86995Nutrition and dietetics services
Scores and ratios are computed by Checked and are not a credit decision.